140 related articles for article (PubMed ID: 12725353)
61. Risk factors for mortality associated with enterococcal bloodstream infections.
Stroud L; Edwards J; Danzing L; Culver D; Gaynes R
Infect Control Hosp Epidemiol; 1996 Sep; 17(9):576-80. PubMed ID: 8880229
[TBL] [Abstract][Full Text] [Related]
62. Prolongation of hospital stay and additional costs due to nosocomial bloodstream infection in an Algerian neonatal care unit.
Atif ML; Sadaoui F; Bezzaoucha A; Kaddache CA; Boukari R; Djelato S; Boubechou N
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1066-70. PubMed ID: 18826372
[TBL] [Abstract][Full Text] [Related]
63. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study.
Landry SL; Kaiser DL; Wenzel RP
Am J Infect Control; 1989 Dec; 17(6):323-9. PubMed ID: 2596729
[TBL] [Abstract][Full Text] [Related]
64. Proportion of hospital deaths potentially attributable to nosocomial infection.
García-Martín M; Lardelli-Claret P; Jiménez-Moleón JJ; Bueno-Cavanillas A; Luna-del-Castillo JD; Gálvez-Vargas R
Infect Control Hosp Epidemiol; 2001 Nov; 22(11):708-14. PubMed ID: 11842992
[TBL] [Abstract][Full Text] [Related]
65. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.
Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
Antimicrob Resist Infect Control; 2020 Aug; 9(1):137. PubMed ID: 32811557
[TBL] [Abstract][Full Text] [Related]
66. Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations.
Freeman J; Epstein MF; Smith NE; Platt R; Sidebottom DG; Goldmann DA
Am J Dis Child; 1990 Mar; 144(3):324-9. PubMed ID: 2305739
[TBL] [Abstract][Full Text] [Related]
67. Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy.
Bond CA; Raehl CL
Am J Health Syst Pharm; 2005 Aug; 62(15):1596-605. PubMed ID: 16030370
[TBL] [Abstract][Full Text] [Related]
68. Hospital costs and mortality attributed to nosocomial bacteremias.
Spengler RF; Greenough WB
JAMA; 1978 Nov; 240(22):2455-8. PubMed ID: 712937
[TBL] [Abstract][Full Text] [Related]
69. Incidence, Clinical Features, Risk Factors and Outcome of Bacteremia due to Vancomycin-Resistant and Vancomycin-Sensitive Enterococcus Species Analyzed Over a 7-year Period in a Single Cancer Institution.
Spanik S; Pichna P; Trupl J; Kunova A; Kralovicova K; Krchnakova A; Kukuckova E; Oravcova E; Demitrovicova A; Krupova I; Stopkova K; Grausova S; Svec J; Botek R; Smid M; Krcmery V
J Infect Chemother; 1996; 2(4):259-263. PubMed ID: 29681377
[TBL] [Abstract][Full Text] [Related]
70. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa.
Carmeli Y; Troillet N; Karchmer AW; Samore MH
Arch Intern Med; 1999 May; 159(10):1127-32. PubMed ID: 10335691
[TBL] [Abstract][Full Text] [Related]
71. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species.
Cosgrove SE; Kaye KS; Eliopoulous GM; Carmeli Y
Arch Intern Med; 2002 Jan; 162(2):185-90. PubMed ID: 11802752
[TBL] [Abstract][Full Text] [Related]
72. Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.
Riu M; Chiarello P; Terradas R; Sala M; Garcia-Alzorriz E; Castells X; Grau S; Cots F
PLoS One; 2016; 11(4):e0153076. PubMed ID: 27055117
[TBL] [Abstract][Full Text] [Related]
73. The association of infectious diseases consultation and 30-day mortality rates among veterans with enterococcal bacteraemia: a propensity score-matched retrospective cohort study.
Tholany J; Suzuki H; Livorsi DJ; Perencevich EN; Goto M
Clin Microbiol Infect; 2023 Aug; 29(8):1039-1044. PubMed ID: 36914070
[TBL] [Abstract][Full Text] [Related]
74. Enterococcal Bacteremia is Associated with Prolonged Stay in the Medical Intensive Care Unit.
Moses V; Jerobin J; Nair A; Sathyendara S; Balaji V; George IA; Peter JV
J Glob Infect Dis; 2012 Jan; 4(1):26-30. PubMed ID: 22529624
[TBL] [Abstract][Full Text] [Related]
75. Hospital-acquired candidemia. The attributable mortality and excess length of stay.
Wey SB; Mori M; Pfaller MA; Woolson RF; Wenzel RP
Arch Intern Med; 1988 Dec; 148(12):2642-5. PubMed ID: 3196127
[TBL] [Abstract][Full Text] [Related]
76. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison.
Haley RW; Schaberg DR; Crossley KB; Von Allmen SD; McGowan JE
Am J Med; 1981 Jan; 70(1):51-8. PubMed ID: 7457491
[TBL] [Abstract][Full Text] [Related]
77. Enterococcal bacteremia in two large community teaching hospitals.
Malone DA; Wagner RA; Myers JP; Watanakunakorn C
Am J Med; 1986 Oct; 81(4):601-6. PubMed ID: 3766590
[TBL] [Abstract][Full Text] [Related]
78. Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis.
Suzuki H; Perencevich EN; Nair R; Livorsi DJ; Goto M
Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32102195
[TBL] [Abstract][Full Text] [Related]
79. Estimating the Effect of Healthcare-Associated Infections on Excess Length of Hospital Stay Using Inverse Probability-Weighted Survival Curves.
Pouwels KB; Vansteelandt S; Batra R; Edgeworth J; Wordsworth S; Robotham JV;
Clin Infect Dis; 2020 Dec; 71(9):e415-e420. PubMed ID: 32047916
[TBL] [Abstract][Full Text] [Related]
80. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital.
Haley RW
Am J Med; 1991 Sep; 91(3B):32S-38S. PubMed ID: 1928186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
